Embolization-induced angiogenesis in cerebral arteriovenous malformations

Endovascular occlusion of cerebral arteriovenous malformations (AVM) is often utilized as adjunctive therapy in combination with radiosurgery or microsurgery. Evidence supports that partial occlusion of AVM via endovascular embolization leads to increased angiogenesis. This phenomenon may be a contributing factor to the decreased efficacy of AVM radiosurgery following embolization. We review the literature for potential mechanisms of embolization-induced angiogenesis. A comprehensive literature search was performed using PubMed to identify studies that sought to elucidate the pathophysiology behind embolization-induced angiogenesis. The terms "arteriovenous malformation", "embolization", and "angiogenesis" were used to search for relevant publications individually and together. Three distinct mechanisms for embolization-induced angiogenesis were described in the literature: (1) hypoxia-mediated angiogenesis, (2) inflammatory-mediated angiogenesis, and (3) hemodynamic-mediated angiogenesis. Embolization-induced angiogenesis of cerebral AVM likely results from a combination of the three aforementioned mechanisms. However, future research is necessary to determine the relative contribution of each individual mechanism to overall post-embolization AVM neovascularization.

[1]  A. Ullrich,et al.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.

[2]  I. Germano,et al.  Histopathological follow-up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol. , 1992, Journal of neurosurgery.

[3]  J. Sheehan,et al.  Radiosurgery for primary motor and sensory cortex arteriovenous malformations: outcomes and the effect of eloquent location. , 2013, Neurosurgery.

[4]  N. Barbaro,et al.  Soluble endoglin modulates aberrant cerebral vascular remodeling , 2009, Annals of neurology.

[5]  D. Kondziolka,et al.  Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. , 2000, International journal of radiation oncology, biology, physics.

[6]  N. Kipshidze,et al.  Avastin-eluting stent: long-term angiographic and clinical follow up. , 2008, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[7]  J. Bahary,et al.  Liquid Embolization Material Reduces the Delivered Radiation Dose: Clinical Myth or Reality? , 2012, American Journal of Neuroradiology.

[8]  Y. Asano,et al.  Sprouting from arteriovenous shunt vessels with increased blood flow , 2006, Medical and Biological Engineering and Computing.

[9]  W. Koch,et al.  Cigarette Smoke Modulates Vascular Smooth Muscle Phenotype: Implications for Carotid and Cerebrovascular Disease , 2013, PloS one.

[10]  M. Zenteno,et al.  Definition of the key target volume in radiosurgical management of arteriovenous malformations: a new dynamic concept based on angiographic circulation time. , 2008, Journal of neurosurgery.

[11]  J. Sheehan,et al.  A practical grading scale for predicting outcome after radiosurgery for arteriovenous malformations: analysis of 1012 treated patients. , 2013, Journal of neurosurgery.

[12]  J. Sheehan,et al.  Radiosurgery for low-grade intracranial arteriovenous malformations. , 2014, Journal of neurosurgery.

[13]  P. Kwok,et al.  Interleukin‐6 involvement in brain arteriovenous malformations , 2006, Annals of neurology.

[14]  M. Lawton,et al.  Suppression of MMP-9 by doxycycline in brain arteriovenous malformations , 2005, BMC Neurology.

[15]  C. McCulloch,et al.  Feasibility of Minocycline and Doxycycline Use as Potential Vasculostatic Therapy for Brain Vascular Malformations: Pilot Study of Adverse Events and Tolerance , 2008, Cerebrovascular Diseases.

[16]  A. Siegel,et al.  Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. , 2001, Journal of neurosurgery.

[17]  M. Forsting,et al.  Embolization of Intracranial Arteriovenous Malformations with Ethylene-Vinyl Alcohol Copolymer (Onyx) , 2008, American Journal of Neuroradiology.

[18]  E. Gizewski,et al.  Proliferation Activity Is Significantly Elevated in Partially Embolized Cerebral Arteriovenous Malformations , 2010, Cerebrovascular Diseases.

[19]  W. Young,et al.  Abnormal Pattern of Tie-2 and Vascular Endothelial Growth Factor Receptor Expression in Human Cerebral Arteriovenous Malformations , 2000, Neurosurgery.

[20]  Lance L. Munn,et al.  Fluid forces control endothelial sprouting , 2011, Proceedings of the National Academy of Sciences.

[21]  N. Barbaro,et al.  Coexpression of Angiogenic Factors in Brain Arteriovenous Malformations , 2005, Neurosurgery.

[22]  M. Neeman,et al.  Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes , 1995, Molecular and cellular biology.

[23]  C. McCulloch,et al.  Doxycycline Suppresses Cerebral Matrix Metalloproteinase-9 and Angiogenesis Induced by Focal Hyperstimulation of Vascular Endothelial Growth Factor in a Mouse Model , 2004, Stroke.

[24]  M. Sluzewski,et al.  Brain AVM embolization with Onyx. , 2007, AJNR. American journal of neuroradiology.

[25]  R. Spetzler,et al.  Surgical management of large AVM's by staged embolization and operative excision. , 1987, Journal of neurosurgery.

[26]  Brian Y. Hwang,et al.  Systemic Expression of Matrix Metalloproteinase‐9 in Patients With Cerebral Arteriovenous Malformations , 2010, Neurosurgery.

[27]  N. Greig,et al.  TNF-α Induces Phenotypic Modulation in Cerebral Vascular Smooth Muscle Cells: Implications for Cerebral Aneurysm Pathology , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  N. Barbaro,et al.  Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations , 2003, Stroke.

[29]  W. Young,et al.  Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain , 2012, Stroke.

[30]  N. Barbaro,et al.  Interleukin-6 Upregulates Expression of KDR and Stimulates Proliferation of Human Cerebrovascular Smooth Muscle Cells , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  D. Ding,et al.  Orbital venous congestion: Rare manifestation of an intracranial arteriovenous malformation , 2014, Journal of Clinical Neuroscience.

[32]  D Lefkopoulos,et al.  Treatment of brain arteriovenous malformations by embolization and radiosurgery. , 1996, Journal of neurosurgery.

[33]  M. Pamir,et al.  Endovascular Treatment Increases but Gamma Knife Radiosurgery Decreases Angiogenic Activity of Arteriovenous Malformations: An in Vivo Experimental Study Using a Rat Cornea Model , 2010, Neurosurgery.

[34]  A. Siegel,et al.  Treatment-induced neoangiogenesis in cerebral arteriovenous malformations , 2001, Clinical Neurology and Neurosurgery.

[35]  K. terBrugge,et al.  EMBOLIZATION BEFORE RADIOSURGERY REDUCES THE OBLITERATION RATE OF ARTERIOVENOUS MALFORMATIONS , 2007, Neurosurgery.

[36]  O. Zaidat,et al.  The diagnosis and management of brain arteriovenous malformations. , 2013, Neurologic clinics.

[37]  J. Sheehan,et al.  Radiosurgery for patients with unruptured intracranial arteriovenous malformations. , 2013, Journal of neurosurgery.

[38]  W. Young,et al.  Minimal Homozygous Endothelial Deletion of Eng with VEGF Stimulation Is Sufficient to Cause Cerebrovascular Dysplasia in the Adult Mouse , 2012, Cerebrovascular Diseases.

[39]  H. Vinters,et al.  Embolization of Arteriovenous Malformations with Onyx: Clinicopathological Experience in 23 Patients , 2001, Neurosurgery.

[40]  D. Kondziolka,et al.  Stereotactic radiosurgery for arteriovenous malformations after embolization: a case-control study. , 2012, Journal of neurosurgery.

[41]  Edward A. Monaco III,et al.  Stereotactic radiosurgery after embolization for arteriovenous malformations. , 2013, Progress in neurological surgery.

[42]  Satoshi O. Suzuki,et al.  Clinicopathological study on chronic encapsulated expanding hematoma associated with incompletely obliterated AVM after stereotactic radiosurgery , 2011, Acta Neurochirurgica.

[43]  T. Sasaguri,et al.  Shear Stress Induces Expression of Vascular Endothelial Growth Factor Receptor Flk-1/KDR Through the CT-Rich Sp1 Binding Site , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[44]  N. Barbaro,et al.  EVIDENCE OF INFLAMMATORY CELL INVOLVEMENT IN BRAIN ARTERIOVENOUS MALFORMATIONS , 2008, Neurosurgery.

[45]  U. Sure,et al.  Hypoxia-inducible Factor and Vascular Endothelial Growth Factor Are Expressed More Frequently in Embolized than in Nonembolized Cerebral Arteriovenous Malformations , 2004, Neurosurgery.

[46]  J. Sheehan,et al.  Outcomes following single-session radiosurgery for high-grade intracranial arteriovenous malformations , 2014, British journal of neurosurgery.

[47]  A. Evans,et al.  Long-term results of gamma knife surgery for partially embolized arteriovenous malformations. , 2012, Neurosurgery.

[48]  Grace H. Kim,et al.  Plasma Levels of Vascular Endothelial Growth Factor After Treatment for Cerebral Arteriovenous Malformations , 2008, Stroke.

[49]  W. Mccormick.  The pathology of vascular ("arteriovenous") malformations. , 1966, Journal of neurosurgery.

[50]  I. Saatci,et al.  Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. , 2011, Journal of neurosurgery.

[51]  S. Rossitti,et al.  Shear stress in cerebral arteries supplying arteriovenous malformations , 2005, Acta Neurochirurgica.

[52]  J. Sheehan,et al.  Radiosurgery for cerebellar arteriovenous malformations: does infratentorial location affect outcome? , 2014, World neurosurgery.

[53]  F. Meyer,et al.  Natural history, evaluation, and management of intracranial vascular malformations. , 2005, Mayo Clinic proceedings.

[54]  H. Winn,et al.  Embolization of cerebral arteriovenous malformations with silk: histopathologic changes and hemorrhagic complications. , 1997, AJNR. American journal of neuroradiology.

[55]  W. Young,et al.  Vascular Endothelial Growth Factor Induces Abnormal Microvasculature in the Endoglin Heterozygous Mouse Brain , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  J. Sheehan,et al.  Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations. , 2014, Journal of neurosurgery.

[57]  E. Aimar,et al.  Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients , 2008, Neuroradiology.

[58]  S. Alper,et al.  702 Identification of Vascular Endothelial Growth Factor (VEGF) as a Flow-Regulated Mediator of Angiogenesis. , 2000, Neurosurgery.

[59]  J. Sheehan,et al.  Radiosurgery for ruptured intracranial arteriovenous malformations. , 2014, Journal of neurosurgery.

[60]  E. D. de Oliveira,et al.  Comprehensive management of arteriovenous malformations. , 1998, Neurological research.